# Safety of Lymph Node Injection for Allergen Immunotherapy

> **NCT01982474** · PHASE1 · UNKNOWN · sponsor: **Amber Patterson** · enrollment: 18 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **BIOLOGICAL:** Grass pollen extract
- **OTHER:** Placebo injection

## Key facts

- **NCT ID:** NCT01982474
- **Lead sponsor:** Amber Patterson
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01982474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01982474, "Safety of Lymph Node Injection for Allergen Immunotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01982474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*